FFCP PHASE1:Mm9::chr7:34974513..34974543,-: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{FFCP|EntrezGene=NA|HGNC=|MCL_coexpression_id=921|UniProt=NA|association_with_transcript=NA|description=CAGE_peak_at_chr7:34974513..34974543,-|id=chr7:34974513..34974543,-|ontology_enrichment_celltype=CL:0000553!2.21e-08!6;CL:0000556!2.21e-08!6|ontology_enrichment_celltype_v019_2=CL:0000553,2.80e-25,6;CL:0000556,2.80e-25,6;CL:0000050,7.35e-17,9;CL:0000839,1.17e-11,13;CL:0000763,1.88e-09,16;CL:0002027,1.11e-08,3;CL:0002006,1.11e-08,3;CL:0002024,1.11e-08,3;CL:0002031,2.07e-08,25;CL:0000049,6.11e-08,19;CL:0000945,2.43e-07,1;CL:0000236,2.43e-07,1;CL:0000826,2.43e-07,1|ontology_enrichment_disease=|ontology_enrichment_disease_v019_2=DOID:0060100,8.96e-18,3;DOID:4045,8.96e-18,3;DOID:0050686,3.48e-09,6|ontology_enrichment_uberon=UBERON:0002106!2.31e-10!6;UBERON:0004457!2.31e-10!6;UBERON:0000042!2.31e-10!6;UBERON:0004854!2.31e-10!6;UBERON:0009034!2.31e-10!6;UBERON:0002095!2.31e-10!6;UBERON:0004782!2.31e-10!6;UBERON:0003281!2.31e-10!6;UBERON:0009664!2.31e-10!6;UBERON:0002296!2.31e-10!6;UBERON:0005602!2.31e-10!6;UBERON:0001179!2.31e-10!6;UBERON:0006293!2.31e-10!6;UBERON:0003887!7.56e-10!10;UBERON:0002193!2.42e-08!48|ontology_enrichment_uberon_v019_2=UBERON:0002204,4.25e-11,32;UBERON:0002371,1.88e-09,16;UBERON:0002193,4.11e-07,48;UBERON:0002405,4.11e-07,48;UBERON:0000029,6.32e-07,1;UBERON:0001097,6.32e-07,1;UBERON:0003968,6.32e-07,1;UBERON:0001467,6.32e-07,1;UBERON:0001474,7.76e-07,22;UBERON:0004765,7.76e-07,22;UBERON:0001434,7.76e-07,22|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.66554880907831,2.63217847606774,0,8.3597473819933,10.2835825204304,13.1560792057389,0,0.0992909512008853,0,0.159992422793407,0.45881856213434,0,0,0,0,0,0.221730510655305,0,0,0,0,0,0,2.09265815368454,2.3440060335714,1.0470474879476,6.47054636834116,8.19654581950135,1.94204141212461,0,0,0,0,0,0,0,0,0,5.70460860596304,0,0,0,0,0,0,0,0,0,0,0,0.988866362566974,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.140444420131752,0,0,0,0,0,0,0,0,0,0,0.22836775943812,1.55362730188303,0,0,0,0,0,0,0,0,0,0.884610551949874,0,0,0,0,0,0,0,0,0,0,0,0.457500602818626,0,0,0,0,0,0,0.124406970610093,0,0.631325567659422,0,0,0.180062129805349,0,0,0,0,0.258703370739016,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.219550115291051,0.134206418760372,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.216138049874694,0,0,0,0,0,0,0,0.0632365371242573,0,0,0,0,0,0,0,0,0,0,0,0.162135226775035,0,0,0,0,0,0,0,0.184753190166605,0,0,0,0,0,0,0,0.157635144106191,0,0.159454768657487,0.491589944147214,0,0.144649058581512,0,0,0.983528546038072,0,0,0,0,0,0,0,0,0.477937595905104,0.445597348164788,0,0,0,0.395287777946524,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.316036757935816,0,0,0,0,0,0.214337035031592,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.73393409276564,0.206386867963223,0.740778109478847,0.753473828018764,0.683471138605126,1.14389086603261,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.632022241256357,0,0,0.129920822977795,0,0,0,0,0,0,0.100826185136841,0,0,0.116876902181569,0.453460767230423,0,0,0,0,0,0,0.214368379079066,0.501572104035363,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.115884325944855,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.231867835620421|short_description=p@chr7:34974513..34974543,-}} | {{FFCP | ||
|DHSsupport=NA | |||
|DPIdataset=NA | |||
|EntrezGene=NA | |||
|HGNC= | |||
|MCL_coexpression_id=921 | |||
|TSSclassifier=NA | |||
|UniProt=NA | |||
|association_with_transcript=NA | |||
|cluster_id=chr7:34974513..34974543,- | |||
|description=CAGE_peak_at_chr7:34974513..34974543,- | |||
|id=chr7:34974513..34974543,- | |||
|ontology_enrichment_celltype=CL:0000553!2.21e-08!6;CL:0000556!2.21e-08!6 | |||
|ontology_enrichment_celltype_v019_2=CL:0000553,2.80e-25,6;CL:0000556,2.80e-25,6;CL:0000050,7.35e-17,9;CL:0000839,1.17e-11,13;CL:0000763,1.88e-09,16;CL:0002027,1.11e-08,3;CL:0002006,1.11e-08,3;CL:0002024,1.11e-08,3;CL:0002031,2.07e-08,25;CL:0000049,6.11e-08,19;CL:0000945,2.43e-07,1;CL:0000236,2.43e-07,1;CL:0000826,2.43e-07,1 | |||
|ontology_enrichment_disease= | |||
|ontology_enrichment_disease_v019_2=DOID:0060100,8.96e-18,3;DOID:4045,8.96e-18,3;DOID:0050686,3.48e-09,6 | |||
|ontology_enrichment_uberon=UBERON:0002106!2.31e-10!6;UBERON:0004457!2.31e-10!6;UBERON:0000042!2.31e-10!6;UBERON:0004854!2.31e-10!6;UBERON:0009034!2.31e-10!6;UBERON:0002095!2.31e-10!6;UBERON:0004782!2.31e-10!6;UBERON:0003281!2.31e-10!6;UBERON:0009664!2.31e-10!6;UBERON:0002296!2.31e-10!6;UBERON:0005602!2.31e-10!6;UBERON:0001179!2.31e-10!6;UBERON:0006293!2.31e-10!6;UBERON:0003887!7.56e-10!10;UBERON:0002193!2.42e-08!48 | |||
|ontology_enrichment_uberon_v019_2=UBERON:0002204,4.25e-11,32;UBERON:0002371,1.88e-09,16;UBERON:0002193,4.11e-07,48;UBERON:0002405,4.11e-07,48;UBERON:0000029,6.32e-07,1;UBERON:0001097,6.32e-07,1;UBERON:0003968,6.32e-07,1;UBERON:0001467,6.32e-07,1;UBERON:0001474,7.76e-07,22;UBERON:0004765,7.76e-07,22;UBERON:0001434,7.76e-07,22 | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.66554880907831,2.63217847606774,0,8.3597473819933,10.2835825204304,13.1560792057389,0,0.0992909512008853,0,0.159992422793407,0.45881856213434,0,0,0,0,0,0.221730510655305,0,0,0,0,0,0,2.09265815368454,2.3440060335714,1.0470474879476,6.47054636834116,8.19654581950135,1.94204141212461,0,0,0,0,0,0,0,0,0,5.70460860596304,0,0,0,0,0,0,0,0,0,0,0,0.988866362566974,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.140444420131752,0,0,0,0,0,0,0,0,0,0,0.22836775943812,1.55362730188303,0,0,0,0,0,0,0,0,0,0.884610551949874,0,0,0,0,0,0,0,0,0,0,0,0.457500602818626,0,0,0,0,0,0,0.124406970610093,0,0.631325567659422,0,0,0.180062129805349,0,0,0,0,0.258703370739016,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.219550115291051,0.134206418760372,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.216138049874694,0,0,0,0,0,0,0,0.0632365371242573,0,0,0,0,0,0,0,0,0,0,0,0.162135226775035,0,0,0,0,0,0,0,0.184753190166605,0,0,0,0,0,0,0,0.157635144106191,0,0.159454768657487,0.491589944147214,0,0.144649058581512,0,0,0.983528546038072,0,0,0,0,0,0,0,0,0.477937595905104,0.445597348164788,0,0,0,0.395287777946524,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.316036757935816,0,0,0,0,0,0.214337035031592,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.73393409276564,0.206386867963223,0.740778109478847,0.753473828018764,0.683471138605126,1.14389086603261,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.632022241256357,0,0,0.129920822977795,0,0,0,0,0,0,0.100826185136841,0,0,0.116876902181569,0.453460767230423,0,0,0,0,0,0,0.214368379079066,0.501572104035363,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.115884325944855,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.231867835620421 | |||
|short_description=p@chr7:34974513..34974543,- | |||
}} |
Latest revision as of 02:53, 5 August 2015
Short description: | p@chr7:34974513..34974543, - |
---|---|
Species: | Mouse (Mus musculus) |
DPI dataset: | NA |
TSS-like-by-RIKEN-classifier(Yes/No): | NA |
DHS support(Yes/No): | NA |
Description: | CAGE_peak_at_chr7:34974513..34974543, - |
Coexpression cluster: | MCL_coexpression_mm9:921 |
Association with transcript: | NA |
EntrezGene: | NA |
Link to Zenbu: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
megakaryocyte progenitor cell | 2.80e-25 | 6 |
megakaryocyte | 2.80e-25 | 6 |
megakaryocyte-erythroid progenitor cell | 7.35e-17 | 9 |
myeloid lineage restricted progenitor cell | 1.17e-11 | 13 |
myeloid cell | 1.88e-09 | 16 |
CD9-positive, CD41-positive megakaryocyte cell | 1.11e-08 | 3 |
Kit-positive, CD34-negative megakaryocyte erythroid progenitor cell | 1.11e-08 | 3 |
Kit-positive megakaryocyte progenitor cell | 1.11e-08 | 3 |
hematopoietic lineage restricted progenitor cell | 2.07e-08 | 25 |
common myeloid progenitor | 6.11e-08 | 19 |
lymphocyte of B lineage | 2.43e-07 | 1 |
B cell | 2.43e-07 | 1 |
pro-B cell | 2.43e-07 | 1 |
Ontology term | p-value | n |
---|---|---|
musculoskeletal system | 4.25e-11 | 32 |
bone marrow | 1.88e-09 | 16 |
hemolymphoid system | 4.11e-07 | 48 |
immune system | 4.11e-07 | 48 |
lymph node | 6.32e-07 | 1 |
axillary lymph node | 6.32e-07 | 1 |
peripheral lymph node | 6.32e-07 | 1 |
shoulder | 6.32e-07 | 1 |
bone element | 7.76e-07 | 22 |
skeletal element | 7.76e-07 | 22 |
skeletal system | 7.76e-07 | 22 |
Ontology term | p-value | n |
---|---|---|
musculoskeletal system cancer | 8.96e-18 | 3 |
muscle cancer | 8.96e-18 | 3 |
organ system cancer | 3.48e-09 | 6 |